Assessment of Inflammatory Biomarkers Expressed in a Sjogren's Population: Effect of a Topical Steroid Intervention
- First Posted Date
- 2008-03-07
- Last Posted Date
- 2010-04-12
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 97
- Registration Number
- NCT00631358
- Locations
- π¨π¦
Waterloo, Waterloo, Canada
π¨π¦Toronto, Toronto, Canada
Adjunctive Study of AL-37807 Ophthalmic Suspension
- First Posted Date
- 2008-02-21
- Last Posted Date
- 2012-12-05
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 129
- Registration Number
- NCT00620256
- Locations
- πΊπΈ
Contact Alcon Call Center at 1-888-451-3937, Fort Worth, Texas, United States
The Natural History of Geographic Atrophy Progression (GAP) Study
Terminated
- Conditions
- First Posted Date
- 2008-01-24
- Last Posted Date
- 2010-03-02
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 1000
- Registration Number
- NCT00599846
- Locations
- πΊπΈ
Houston, Houston, Texas, United States
A Phase II Study of Moxidex Ophthalmic Solution for Treatment of Marginal Corneal Infiltrates
- First Posted Date
- 2007-12-21
- Last Posted Date
- 2012-12-05
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 144
- Registration Number
- NCT00579020
- Locations
- πΊπΈ
Contact Alcon Call Center at 1-888-451-3937, Fort Worth, Texas, United States
A Phase III Study of an Otic Formulation in Acute Otitis Media With Tympanostomy Tubes
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-12-21
- Last Posted Date
- 2012-12-03
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 911
- Registration Number
- NCT00578474
A Phase II Study of an Otic Formulation in Treating Peri-Operative Tube Otorrhea
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-12-21
- Last Posted Date
- 2012-12-03
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 303
- Registration Number
- NCT00578773
Phase III Study of an Otic Formulation in Acute Otitis Media With Tympanostomy Tubes
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-12-21
- Last Posted Date
- 2012-12-03
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 776
- Registration Number
- NCT00579189
Safety Study of Olopatadine Nasal Spray
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-12-21
- Last Posted Date
- 2017-10-31
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 890
- Registration Number
- NCT00578331
- Locations
- πΊπΈ
Waco, Waco, Texas, United States
Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-12-21
- Last Posted Date
- 2010-03-02
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 2388
- Registration Number
- NCT00578929
- Locations
- πΊπΈ
Kenilworth/IL, Kenilworth, Illinois, United States
TOBRADEX Ophthalmic Suspension Versus Tobramycin 0.3%/Dexamethasone 0.05% Ophthalmic Suspension
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-12-19
- Last Posted Date
- 2010-03-02
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 221
- Registration Number
- NCT00576251
- Locations
- πΊπΈ
Houston, Houston, Texas, United States
Β© Copyright 2024. All Rights Reserved by MedPath